Park Kwang-seok Acquires 9,455,845 Shares at 500 Won via Debt-to-Equity Swap Under Rehabilitation Plan, Stake at 15.87%: Massive Dilution Threatens Shareholder Value
Park Kwang-seok (manager at UNION KOREA PHARM) acquired 9,455,845 common shares at 500 won per share through a debt-to-equity swap as part of the rehabilitation plan, becoming a major shareholder with a 15.87% stake.
The debt-to-equity swap converts liabilities into equity, significantly increasing total outstanding shares to 59,573,136, thus diluting existing shareholders' ownership.
The acquisition price (500 won) is far below the current market price (2,725 won), effectively a deep discount issuance, raising concerns of downward price pressure due to increased supply.
Given the ongoing rehabilitation, further dilutive events or capital reductions may occur, posing substantial long-term risk.
[AI Overall Analysis]While this debt-to-equity swap may have been necessary for the company's rehabilitation, existing shareholders face unavoidable dilution and losses from the low-priced issuance. Caution is advised due to potential short-term stock price decline.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders